In Vitro Ototoxicity of aminoglycosides and platin derivatives. A semi-automatic assay for sensory hair cell damage in explanted rat organ of corti

Toxicology in Vitro : an International Journal Published in Association with BIBRA
B MalgrangeG Moonen

Abstract

The ototoxic damage that drugs such as neomycin, kanamycin, colistin, cisplatin, transplatin and carboplatin cause on outer and inner hair cells in postnatal day 3 rat cochlear explants was investigated. Phalloidin-fluorescein conjugate-stained stereocilia bundles of sensory hair cells were quantified by video image analysis as a measurement of ototoxic effect. The video image quantification system established dose-response curves for ototoxic drugs (e.g. calculation of an IC(50)) and allowed comparisons between several ototoxins from the same family. This methodology provided the means to assess the efficacy of otoprotectant agents in preventing ototoxicity. Poly-l-aspartate (10(-5)m) and poly-l-glutamate (10(-5)m) protected auditory hair cells from neomycin (10(-3)m) toxicity while reduced glutathione (10(-3)m) provided protection against cisplatin (10(-4)m)-induced hair cell damage.

References

Jan 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·J E Bottenstein, G H Sato
Jan 1, 1992·Audiology : Official Organ of the International Society of Audiology·M TaudyL Ulehlová
Jun 1, 1991·Hearing Research·G P Richardson, I J Russell
Jun 1, 1990·The American Journal of Physiology·L RamsammyG J Kaloyanides
Jan 1, 1989·Auris, Nasus, Larynx·T SaitoG Tsuda
Jan 1, 1989·Auris, Nasus, Larynx·M TakumidaJ Wersäll
Mar 1, 1989·Toxicology Letters·P M Tulkens
Jan 1, 1986·Hearing Research·J Schacht
Apr 1, 1986·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·V G SchweitzerC Sheridan
Nov 1, 1980·Kidney International·J P MorinJ P Fillastre
Jan 24, 1980·Nature·A B Kroese, J van den Bercken
Mar 1, 1981·Hearing Research·M G Pierson, A R Møller
Mar 1, 1981·The Journal of Infectious Diseases·P Tran Ba HuyC Amiel
Jan 1, 1995·Acta Oto-laryngologica. Supplementum·J Wersäll
Jul 1, 1995·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·L P RybakS M Somani
Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S CascinuG Catalano
Jan 1, 1994·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·A A Chiodo, P W Alberti
Jul 1, 1994·International Journal of Radiation Oncology, Biology, Physics·G CavalettiG Tredici
Jan 1, 1993·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F Di ReF Zunino
Apr 30, 1993·Science·P P LefebvreT R Van de Water
Mar 1, 1995·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·N. ColomboC. Mangioni

❮ Previous
Next ❯

Citations

Sep 5, 2002·Hearing Research·Brigitte MalgrangePhilippe P Lefebvre
Jul 24, 2014·Cell Biology International·Xiangxin LouYanzhong Zhang
Feb 13, 2007·Phonetica·Philippe Boula de Mareüil, Bianca Vieru-Dimulescu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.